Falcon Point Capital LLC lowered its stake in Maximus Inc. (NYSE:MMS) by 52.4% during the second quarter, Holdings Channel reports. The firm owned 135,679 shares of the company’s stock after selling 149,166 shares during the period. Falcon Point Capital LLC’s holdings in Maximus were worth $7,513,000 at the end of the most recent reporting period.
A number of other large investors also recently modified their holdings of MMS. Massmutual Trust Co. FSB ADV boosted its position in shares of Maximus by 3.6% in the first quarter. Massmutual Trust Co. FSB ADV now owns 3,879 shares of the company’s stock valued at $204,000 after buying an additional 134 shares in the last quarter. Parametrica Management Ltd acquired a new position in shares of Maximus during the second quarter valued at approximately $216,000. LS Investment Advisors LLC boosted its position in shares of Maximus by 70.9% in the second quarter. LS Investment Advisors LLC now owns 3,928 shares of the company’s stock valued at $217,000 after buying an additional 1,630 shares in the last quarter. Capstone Asset Management Co. boosted its position in shares of Maximus by 16.9% in the second quarter. Capstone Asset Management Co. now owns 7,262 shares of the company’s stock valued at $402,000 after buying an additional 1,050 shares in the last quarter. Finally, Mount Lucas Management LP boosted its position in shares of Maximus by 10.4% in the first quarter. Mount Lucas Management LP now owns 9,073 shares of the company’s stock valued at $478,000 after buying an additional 853 shares in the last quarter. Hedge funds and other institutional investors own 99.00% of the company’s stock.
Shares of Maximus Inc. (NYSE:MMS) traded down 0.84% during mid-day trading on Friday, reaching $57.54. 172,544 shares of the company’s stock were exchanged. The firm has a market cap of $3.73 billion, a P/E ratio of 23.51 and a beta of 1.12. Maximus Inc. has a 52-week low of $45.15 and a 52-week high of $69.85. The company has a 50 day moving average price of $58.46 and a 200 day moving average price of $55.49.
Maximus (NYSE:MMS) last released its earnings results on Thursday, August 4th. The company reported $0.75 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.71 by $0.04. The firm had revenue of $617.10 million for the quarter, compared to analysts’ expectations of $625.62 million. Maximus had a net margin of 6.91% and a return on equity of 23.89%. The company’s quarterly revenue was up 7.8% on a year-over-year basis. During the same period in the previous year, the company earned $0.62 earnings per share. Analysts forecast that Maximus Inc. will post $2.65 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Wednesday, August 31st. Shareholders of record on Monday, August 15th were paid a $0.045 dividend. This represents a $0.18 dividend on an annualized basis and a yield of 0.31%. The ex-dividend date was Thursday, August 11th. Maximus’s payout ratio is 7.32%.
MMS has been the topic of several recent research reports. Jefferies Group raised their target price on shares of Maximus from $63.00 to $67.00 and gave the stock a “buy” rating in a report on Tuesday, May 31st. KeyCorp assumed coverage on shares of Maximus in a research note on Thursday, June 30th. They issued an “overweight” rating and a $63.00 price objective on the stock. Zacks Investment Research cut shares of Maximus from a “hold” rating to a “sell” rating in a research note on Wednesday, August 3rd. Finally, Maxim Group lifted their price objective on shares of Maximus from $71.00 to $74.00 and gave the company a “buy” rating in a research note on Thursday, August 4th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and seven have given a buy rating to the company. Maximus presently has a consensus rating of “Buy” and a consensus target price of $63.00.
In related news, President Bruce Caswell sold 30,000 shares of the company’s stock in a transaction that occurred on Thursday, August 18th. The shares were sold at an average price of $58.98, for a total transaction of $1,769,400.00. Following the sale, the president now directly owns 39,386 shares in the company, valued at approximately $2,322,986.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Raymond B. Ruddy sold 18,000 shares of the company’s stock in a transaction that occurred on Thursday, July 14th. The shares were sold at an average price of $60.00, for a total transaction of $1,080,000.00. Following the sale, the director now owns 295,552 shares in the company, valued at $17,733,120. The disclosure for this sale can be found here. 3.60% of the stock is currently owned by company insiders.
Maximus Company Profile
MAXIMUS, Inc provides business process services (BPS) to Government health and human services agencies. The Company is primarily focused on operating Government-sponsored programs, such as Medicaid, children’s health insurance program (CHIP), health insurance exchanges and other health care reform initiatives, Medicare, welfare-to-work, child support services and other Government programs.
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus Inc. (NYSE:MMS).
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.